查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750868

药物筛检市场规模、份额、趋势分析报告（按产品类型、样品类型、最终用途、地区、细分市场预测），2025 年至 2030 年

Drug Screening Market Size, Share & Trends Analysis Report By Product Type (Instruments, Consumables), By Sample Type (Urine Sample, Breath Sample), By End-use (Drug Treatment Centers), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

药物筛检市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球药物筛检市场规模预计到2030年将达到119.9亿美元，预计2025年至2030年期间的复合年增长率为4.1%。

推动这一市场发展的因素包括人们对职场安全、法规遵从性以及检测方法技术进步推动的对药物滥用的准确检测要求日益增长的担忧。

英国接受药物和酒精服务机构治疗的成年人数量增加了4.8%，从2020-2021年的275,896人增加到2021-2022年的289,215人，这表明该国药物滥用的流行程度正在加剧。药物滥用的日益普遍进一步表明，有必要製定有效的预防和治疗策略，包括扩大循证治疗方案的可及性，并开展公共卫生宣传活动，以提高公众对药物和酒精滥用风险的认识。

此外，2020年12岁以上美国非法药物使用率约为3,731万，与过去与前一年同期比较相比成长了3.8%。这一增长凸显了在职场、学校和医疗保健机构中开展全面药物筛检计画的迫切需求，以确保安全、合规，并为那些正在与药物滥用作斗争的人提供适当的护理和支持。

此外，新产品发布、併购等市场参与者的倡议也促进了市场成长。例如，2024年2月，纽约领先的药物检测提供者Mobile Health为雇主推出了快速药物检测服务，可在一小时内获得结果。这项创新专注于尿液检测，以其准确性和多功能性而闻名，它改进了招聘流程，并彻底改变了纽约的人才招募方式。此外，2023年12月，AvertD测试获得美国食品药物管理局（FDA）核准，该测试透过基因标记评估个体患有阿片类药物使用障碍的风险，使其成为应对阿片类药物危机的关键创新。该测试由AutoGenomics公司开发，旨在用于患者首次接触口服鸦片类止痛药之前，尤其适用于那些计划接受手术的患者。该测试旨在帮助患者和医疗保健提供者就阿片类药物的使用做出明智的决定，从而潜在地降低成瘾和滥用的风险。

药物筛检市场报告重点

  • 由于耗材在快速、准确和现场检测中发挥重要作用，预计到2024年，其收入份额将达到34.5%。此外，频繁的产品发布以及职场和医疗保健环境中对高效物质检测的需求也在推动这一细分市场的成长。
  • 由于对专业药物筛检服务（例如实验室分析和法规遵从支援）的需求不断增长，预计预测期内其他服务的复合年增长率为 4.1%。
  • 尿液样本将占据市场主导地位，到 2024 年将占据 41.3% 的最大收益占有率，这主要是因为其非侵入性、简单且方便的收集过程，使其适用于职场和临床环境。
  • 由于易于收集、隐私问题较少以及样本污染风险低，预计预测期内口腔液样本将以显着的复合年增长率成长。
  • 药物治疗将引领市场，占据 2024 年最大的收益占有率。预计从 2025 年到 2030 年，医院的复合年增长率最快，为 5.2%。
  • 受药物滥用率上升、职场安全法规严格以及政府措施不断增多的推动，北美将在 2024 年占据全球药物筛检市场的最大收益占有率。

目录

第一章调查方法与范围

第二章执行摘要

第三章全球药物筛检市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 全球药物筛检市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析

第四章全球药物筛检市场：产品类型商业分析

  • 产品类型细分仪表板
  • 药物筛检市场：产品类型变化分析
  • 2018-2030年全球药物筛检市场规模及趋势分析（依产品类型）
  • 装置
  • 快速检测装置
  • 耗材
  • 服务及更多

第五章全球药物筛检市场：样本类型商业分析

  • 样本类型细分仪表板
  • 药物筛检市场：样本类型变异分析
  • 2018-2030年全球药物筛检市场规模及趋势分析（依样本类型）
  • 尿液样本
  • 呼气样本
  • 口腔液体样本
  • 头髮样本
  • 其他样品

6. 全球药物筛检市场：最终用途业务分析

  • 最终用途细分仪表板
  • 药物筛检市场：最终用途变异分析
  • 2018-2030年全球药物筛检市场规模及趋势分析（依最终用途）
  • 医院
  • 刑事司法和执法
  • 职场
  • 药物治疗中心
  • 个人用户
  • 疼痛管理中心
  • 学校和大学
  • 其他的

7. 全球药物筛检市场：区域估计与趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 全球药物筛检市场（按地区）: 关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
  • 公司简介
    • Abbott
    • Quest Diagnostics Incorporated
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Siemens Healthcare AG
    • Laboratory Corporation of America Holdings
    • Alfa Scientific Designs, Inc.
    • OraSure Technologies, Inc.
    • Omega Laboratories, Inc.
    • Dragerwerk AG &Co. KGaA
    • Bio-Rad Laboratories, Inc.
Product Code: GVR-4-68040-303-9

Drug Screening Market Growth & Trends:

The global drug screening market size is estimated to reach USD 11.99 billion by 2030 and is anticipated to expand at a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increasing workplace safety concerns, regulatory compliance, and the requirement for accurate detection of substance abuse, aided by technological advancements in testing methods.

The increase in number of adults in contact with drug and alcohol services in England has increased from 275,896 in 2020 - 2021¬ to 289,215 in 2021 - 2022, representing a 4.8% rise, which signifies a growing prevalence of substance abuse in the country. The rising prevalence of substance abuse further propels the need for effective prevention and treatment strategies, including the expansion of access to evidence-based treatment options and public health campaigns to raise awareness about the risks of drug and alcohol misuse.

Furthermore, the incidence of illegal substance uses amongst Americans aged 12 and older in 2020 was around 37.31 million, and shows a 3.8% year-over-year increase over the years; this rising prevalence serves as a significant driver for the market. This increase highlights the urgent need for comprehensive drug screening programs in workplaces, schools, and healthcare settings to ensure safety, compliance with regulations, and provision of appropriate care and support for individuals struggling with substance abuse.

Furthermore, initiatives by market players such as new product launches, mergers, acquisitions, and others contribute to market growth. For instance, in February 2024, Mobile Health, the leading drug testing provider in NYC, launched rapid drug testing for employers, ensuring results in an hour or less. With a focus on urine-based testing for accuracy and versatility, this innovation advances the hiring procedure, revolutionizing talent acquisition in NYC. In addition, in December 2023, the FDA's approval of the AvertD test, which assesses an individual's risk of developing opioid use disorder through genetic markers, marks a significant innovation in the fight against the opioid crisis. This test, developed by AutoGenomics, Inc., is designed to be used before a patient is first exposed to oral opioid pain medications, particularly in patients scheduled for surgical procedures. The test is intended to help patients and healthcare providers make informed decisions about opioid use, potentially reducing the risk of addiction and misuse.

Drug Screening Market Report Highlights:

  • Consumables held the largest revenue share of 34.5% in 2024, attributed to their essential role in rapid, accurate, and on-site testing. Furthermore, frequent product launches and the need for efficient substance detection across workplaces and healthcare settings also fuel this segment's growth
  • Services and others are expected to grow at a CAGR of 4.1% over the forecast period, owing to the increasing need for specialized drug screening services, including laboratory analysis and support for compliance with regulatory standards.
  • Urine samples dominated the market with the largest revenue share of 41.3% in 2024, primarily driven by their noninvasive, simple, and convenient collection process, which makes them suitable for both workplace and clinical settings.
  • Oral fluid samples are expected to grow at a significant CAGR over the forecast period, driven by their ease of collection, minimal privacy concerns, and lower risk of sample adulteration.
  • In 2024, drug treatment led the market and accounted for the largest revenue share. Hospitals are expected to grow at the fastest CAGR of 5.2% from 2025 to 2030.
  • North America dominated the global drug screening market with the largest revenue share in 2024, driven by rising substance abuse rates, stringent workplace safety regulations, and increasing government initiatives aimed at controlling drug-related issues.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Sample Type
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Type Outlook
    • 2.2.2. Sample Type Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Drug Screening Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Drug Screening Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Drug Screening Market: Product Type Business Analysis

  • 4.1. Product Type Segment Dashboard
  • 4.2. Drug Screening Market: Product Type Movement Analysis
  • 4.3. Global Drug Screening Market Size & Trend Analysis, By Product Type, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Immunoassays Analyzers
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Chromatography Instruments
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Breath Analyzer
      • 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.4.4.2. Fuel Cell Breath Analyzer
        • 4.4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.4.4.3. Semi-Conductor Breath Analyzer
        • 4.4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.4.4.4. Others Breath Analyzer
        • 4.4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Rapid Testing Devices
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Urine Testing Devices
      • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.5.2.2. Drug Testing Cups
        • 4.5.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.5.2.3. Dip Cards
        • 4.5.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.5.2.4. Drug Testing Cassettes
        • 4.5.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Oral Fluid Testing Devices
    • 4.5.4. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Consumables
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Assay Kits
      • 4.6.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Sample Collection Devices
      • 4.6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Calibrators & Controls
      • 4.6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Other Consumables
      • 4.6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.7. Services & Others
    • 4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Drug Screening Market: Sample Type Business Analysis

  • 5.1. Sample Type Segment Dashboard
  • 5.2. Drug Screening Market: Sample Type Movement Analysis
  • 5.3. Global Drug Screening Market Size & Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
  • 5.4. Urine Samples
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Breath Samples
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Oral Fluid Samples
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Hair Samples
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Other Samples
    • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Drug Screening Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Drug Screening Market: End Use Movement Analysis
  • 6.3. Global Drug Screening Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Criminal Justice & Law Enforcement Agencies
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Workplaces
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7. Drug Treatment Centers
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8. Individual Users
    • 6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.9. Pain Management Centers
    • 6.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.10. Schools & Colleges
    • 6.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Drug Screening Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Global Drug Screening Market by Regional: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Quest Diagnostics Incorporated
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. F. Hoffmann-La Roche Ltd
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Thermo Fisher Scientific Inc.
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Siemens Healthcare AG
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Laboratory Corporation of America Holdings
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Alfa Scientific Designs, Inc.
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. OraSure Technologies, Inc.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Omega Laboratories, Inc.
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Dragerwerk AG & Co. KGaA
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Bio-Rad Laboratories, Inc.
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives

List of Tables

  • Table 1. List Of Abbreviations
  • Table 2. Global Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 3. Global Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 4. Global Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5. Global Drug Screening Market, By Region, 2018 - 2030 (USD Million)
  • Table 6. North America Drug Screening Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 8. North America Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 9. North America Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10. U.S. Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 11. U.S. Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 12. U.S. Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13. Canada Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 14. Canada Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 15. Canada Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16. Mexico Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 17. Mexico Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 18. Mexico Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19. Europe Drug Screening Market, By Country, 2018 - 2030 (USD Million)
  • Table 20. Europe Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 21. Europe Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 22. Europe Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 23. Germany Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 24. Germany Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 25. Germany Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26. UK Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 27. UK Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 28. UK Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29. France Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 30. France Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 31. France Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32. Italy Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 33. Italy Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 34. Italy Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35. Spain Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 36. Spain Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 37. Spain Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38. Denmark Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 39. Denmark Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 40. Denmark Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. Sweden Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 42. Sweden Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 43. Sweden Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44. Norway Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 45. Norway Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 46. Norway Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Drug Screening Market, By Country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51. China Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 52. China Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 53. China Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54. Japan Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 55. Japan Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 56. Japan Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57. India Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 58. India Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 59. India Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 60. South Korea Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 61. South Korea Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 62. South Korea Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63. Australia Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 64. Australia Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 65. Australia Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66. Thailand Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 67. Thailand Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 68. Thailand Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69. Latin America Drug Screening Market, By Country, 2018 - 2030 (USD Million)
  • Table 70. Latin America Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 71. Latin America Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 72. Latin America Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73. Brazil Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 74. Brazil Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 75. Argentina Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 76. Argentina Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 77. Argentina Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78. MEA Drug Screening Market, By Region, 2018 - 2030 (USD Million)
  • Table 79. MEA Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 80. MEA Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 81. MEA Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82. South Africa Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 83. South Africa Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 84. South Africa Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85. Saudi Arabia Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88. UAE Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 89. UAE Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 90. UAE Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91. Kuwait Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 92. Kuwait Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 93. Kuwait Drug Screening Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Sample Types
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Drug Screening Market: Market Outlook
  • Fig. 10 Drug Screening Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Drug Screening Market Driver Impact
  • Fig. 16 Drug Screening Market Restraint Impact
  • Fig. 17 Drug Screening Market Strategic Initiatives Analysis
  • Fig. 18 Drug Screening Market: Product Type Movement Analysis
  • Fig. 19 Drug Screening Market: Product Type Outlook and Key Takeaways
  • Fig. 20 Instruments Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Rapid Testing Devices Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Consumables Market Estimates and Forecast, 2018 - 2030
  • Fig. 23 Services & Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 24 Drug Screening Market: Sample Type Movement Analysis
  • Fig. 25 Drug Screening Market: Sample Type Outlook and Key Takeaways
  • Fig. 26 Urine Samples Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Breath Samples Market Estimates and Forecast, 2018 - 2030
  • Fig. 28 Oral Fluid Samples Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Hair Samples Market Estimates and Forecast, 2018 - 2030
  • Fig. 30 Other Samples Market Estimates and Forecast, 2018 - 2030
  • Fig. 31 Drug Screening Market: End Use Movement Analysis
  • Fig. 32 Drug Screening Market: End Use Outlook and Key Takeaways
  • Fig. 33 Hospitals Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 Criminal Justice & Law Enforcement Agencies Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Workplaces Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 Drug Treatment Centers Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Individual Users Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 Pain Management Centers Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Schools & Colleges Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Global Drug Screening Market: Regional Movement Analysis
  • Fig. 42 Global Drug Screening Market: Regional Outlook and Key Takeaways
  • Fig. 43 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 67 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 69 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 70 Kuwait Market Estimates and Forecasts, 2018 - 2030